South Africa drops probe of J&J after it agrees to lower price of TB drug and withdraws patent
CAPE TOWN, South Africa — Medical advocacy groups welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices, …